Indian-origin scientist identifies four possible drugs to treat COVID-19The study, published in the journal Pathogens, found that all four drugs were effective in inhibiting, or blocking, the coronavirus' RNA pr...
Coronavirus outbreak: How much testing should we do, and where are we on developing a vaccine?Over 170,000 individuals across the world have been infected by the novel coronavirus and 6,509 have died, with cases and deaths outside Ch...
Nipah Virus: CM Pinarayi Vijayan chairs high-level meet to review preventive measuresDirections have been given to continue vigil and to strengthen the state's monitoring mechanism, besides increasing awareness about the vir...
Nipah: Travellers asked to avoid 4 Kerala districtsSurveillance by the government is being conducted in Kozhikode district, from where most of the cases were reported.
India may soon get treatment for Hepatitis CThe drug called Epclusa which is developed to treat all genotypes of the Hepatitis C virus by Gilead Sciences in its latest breakthrough tr...
Hepatitis C cure may cost as low as Rs 67,000India is now one of the few countries where generics are available for interferon-free treatment of Hepatitis C.
Cure for Hepatitis C in HIV patients on the cardsApproximately one-third of HIV patients in the US have hepatitis C, with an estimated 7 million co-infected patients worldwide.
New drug combo cures toughest cases of hepatitis CResults were similar in study participants infected with genotypes 2 or 3, strains which are less common in the US.
- Satyam’s Raju gets bail on health grounds
Ramalinga Raju, the former chairman of Satyam Computer Services, who triggered one of Corporate India’s biggest fraud investigation by admi...